Galectin Therapeutics Inc. appointed Benjamin S. Carson, Sr., M.D. as a new member of the Board of Directors, following his service as a senior advisor to the Company since 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 USD | 0.00% | -5.57% | +83.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+83.73% | 189M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- GALT Stock
- News Galectin Therapeutics Inc.
- Galectin Therapeutics Inc. Appoints Benjamin S. Carson as Member of the Board of Directors